Tech Company Financing Transactions
201 Therapeutics Funding Round
Venture Kick participated in a $180 thousand funding round for 201 Therapeutics. The round was recorded on 11/16/2026.
Transaction Overview
Company Name
Announced On
11/16/2026
Transaction Type
Venture Equity
Amount
$180,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to optimize its lead drug candidates, generate preclinical efficacy data in animal models, select a development candidate, and prepare for future investment and pharmaceutical partnerships.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Hebelstrasse 20
Basel, 4031
Switzerland
Basel, 4031
Switzerland
Phone
Undisclosed
Email Address
Not Recorded
Overview
201 Therapeutics develops a new class of small-molecule therapies that directly target liver cancer cells, an approach fundamentally different from current treatments, which mainly act on the tumor microenvironment and leave the majority of patients without durable benefit. Our discovery engine is built on a unique biobank of biopsy-derived hepatocellular carcinoma (HCC) organoids, enabling drug discovery directly in patient tumor cells with strong translational relevance. Two structurally novel small-molecule series are advancing toward preclinical development, with the goal of bringing effective options to patients who currently have none.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/16/2026: Alecto Conveyancing venture capital transaction
Next: 11/16/2026: Evotec venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








